1997 Establishment of the gut microbiota symbiotic fermentation technology
2000 Established Microbio Co., Ltd.
2001 Longtan Plant was established and passed the GMP certification
MS-20 (Chemo young) conducts the phase III of human clinical trials
2004 Established Microbio (Shanghai) Co., Ltd.
Established Taiwan's first "New Drug Research and Development Center"
2006 Microbio’s stock has been officially listed on over the counter market (4128)
2008 MB-6 obtained the US FDA Phase II Human Clinical Trial approval
Became the first "Biotech New Drug Company" in Taiwan
Herbiron conducts Phase III human clinical trials
2011 MS-20 (Chemo young) obtained the first certificate of oral solution for cancer new drug.
2013 Herbiron obtained the first compound herbs new drug certificate
MB-6 conducts Phase III human clinical trials
2015 Herbiron wins Biomedical Quality Award
MB-110 (anti-C hepatitis new drug) passed the US FDA phase I human clinical trial application
2016 Joint development of the Pingtung County Nanjhou Township with ONENESS to establish PIC/S GMP Pharmaceutical Factory and Sightseeing Pharmaceutical Factory Park
2018 MS-20 (Chemo young) obtained invention patents in Taiwan, the United States, Japan, Hong Kong, South Korea, Europe and Indonesia